Literature DB >> 17909983

Inhibition on Candida albicans biofilm formation using divalent cation chelators (EDTA).

Gordon Ramage1, Brian L Wickes, José L López-Ribot.   

Abstract

Candida albicans can readily form biofilms on both inanimate and biological surfaces. In this study we investigated a means of inhibiting biofilm formation using EDTA (Ethylenediaminetetra-acetic acid), a divalent cation chelating agent, which has been shown to affect C. albicans filamentation. Candida albicans biofilms were formed in 96-well microtitre plates. Cells were allowed to adhere for 1, 2, and 4 h at 37 degrees C, washed in PBS, and then treated with different concentrations of EDTA (0, 2.5, 25, and 250 mM). EDTA was also added to the standardized suspension prior to adding to the microtiter plate and to a preformed 24 h biofilm. All plates were then incubated at 37 degrees C for an additional 24 h to allow for biofilm formation. The extent and characteristics of biofilm formation were then microscopically assessed and with a semi-quantitative colorimetric technique based on the use of an XTT-reduction assay. Northern blot analysis of the hyphal wall protein (HWP1) expression was also monitored in planktonic and biofilm cells treated with EDTA. Microscopic analysis and colorimetric readings revealed that filamentation and biofilm formation were inhibited by EDTA in a concentration dependent manner. However, preformed biofilms were minimally affected by EDTA (maximum of 31% reduction at 250 mM). The HWP1 gene expression was reduced in EDTA-treated planktonic and biofilm samples. These results indicate that EDTA inhibits C. albicans biofilm formation are most likely through its inhibitory effect on filamentation and indicates the potential therapeutic effects of EDTA. This compound may serve a non-toxic means of preventing biofilm formation on infections with a C. albicans biofilm etiology.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17909983     DOI: 10.1007/s11046-007-9068-x

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  30 in total

Review 1.  Biofilm formation: a clinically relevant microbiological process.

Authors:  R M Donlan
Journal:  Clin Infect Dis       Date:  2001-09-20       Impact factor: 9.079

Review 2.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

Review 3.  Candida biofilms on implanted biomaterials: a clinically significant problem.

Authors:  Gordon Ramage; José Pedro Martínez; José Luis López-Ribot
Journal:  FEMS Yeast Res       Date:  2006-11       Impact factor: 2.796

Review 4.  Candida albicans biofilms: more than filamentation.

Authors:  José L López-Ribot
Journal:  Curr Biol       Date:  2005-06-21       Impact factor: 10.834

5.  Influence of a calcium-specific chelant on biofilm removal.

Authors:  M H Turakhia; K E Cooksey; W G Characklis
Journal:  Appl Environ Microbiol       Date:  1983-11       Impact factor: 4.792

6.  Role of dimorphism in the development of Candida albicans biofilms.

Authors:  George S Baillie; L Julia Douglas
Journal:  J Med Microbiol       Date:  1999-07       Impact factor: 2.472

Review 7.  Genetics and genomics of Candida albicans biofilm formation.

Authors:  Clarissa J Nobile; Aaron P Mitchell
Journal:  Cell Microbiol       Date:  2006-07-11       Impact factor: 3.715

Review 8.  Candida infections of medical devices.

Authors:  Erna M Kojic; Rabih O Darouiche
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

9.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System.

Authors:  C Beck-Sagué; W R Jarvis
Journal:  J Infect Dis       Date:  1993-05       Impact factor: 5.226

10.  Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection.

Authors:  Stephen P Saville; Anna L Lazzell; Carlos Monteagudo; Jose L Lopez-Ribot
Journal:  Eukaryot Cell       Date:  2003-10
View more
  12 in total

1.  Eighty Years of Mycopathologia: A Retrospective Analysis of Progress Made in Understanding Human and Animal Fungal Pathogens.

Authors:  Vishnu Chaturvedi; Jean-Philippe Bouchara; Ferry Hagen; Ana Alastruey-Izquierdo; Hamid Badali; Anamelia Lorenzetti Bocca; Jose F Cano-Lira; Cunwei Cao; Sudha Chaturvedi; Sanjay H Chotirmall; Anne D van Diepeningen; Jean-Pierre Gangneux; Jesus Guinea; Sybren de Hoog; Macit Ilkit; Rui Kano; Weida Liu; Nilce M Martinez-Rossi; Marcia de Souza Carvalho Melhem; Mario Augusto Ono; Yuping Ran; Stephane Ranque; Celia Maria de Almeida Soares; Takashi Sugita; Philip A Thomas; Anna Vecchiarelli; Nancy L Wengenack; Patrick C Y Woo; Jianping Xu; Rosely M Zancope-Oliveira
Journal:  Mycopathologia       Date:  2018-11-30       Impact factor: 2.574

2.  Efficacy of zosteric acid sodium salt on the yeast biofilm model Candida albicans.

Authors:  Federica Villa; Betsey Pitts; Philip S Stewart; Barbara Giussani; Simone Roncoroni; Domenico Albanese; Carmen Giordano; Marta Tunesi; Francesca Cappitelli
Journal:  Microb Ecol       Date:  2011-05-26       Impact factor: 4.552

3.  A Novel Polyaminocarboxylate Compound To Treat Murine Pulmonary Aspergillosis by Interfering with Zinc Metabolism.

Authors:  Paris Laskaris; Rocío Vicentefranqueira; Olivier Helynck; Grégory Jouvion; José Antonio Calera; Laurence du Merle; Franck Suzenet; Frédéric Buron; Rodolphe Alves de Sousa; Daniel Mansuy; Jean-Marc Cavaillon; Jean-Paul Latgé; Hélène Munier-Lehmann; Oumaima Ibrahim-Granet
Journal:  Antimicrob Agents Chemother       Date:  2018-05-25       Impact factor: 5.191

4.  EDTA inhibits biofilm formation, extracellular vesicular secretion, and shedding of the capsular polysaccharide glucuronoxylomannan by Cryptococcus neoformans.

Authors:  Emma J Robertson; Julie M Wolf; Arturo Casadevall
Journal:  Appl Environ Microbiol       Date:  2012-08-31       Impact factor: 4.792

5.  Quorum protection, growth and survival.

Authors:  Ian G Macreadie
Journal:  Microb Cell       Date:  2015-01-23

6.  Heparin-benzyl alcohol enhancement of biofilms formation and antifungal susceptibility of vaginal Candida species isolated from pregnant and nonpregnant Saudi women.

Authors:  Raid A Al-Akeel; Talat A El-Kersh; Yazeed A Al-Sheikh; Ziab Zakey Al-Ahmadey
Journal:  Bioinformation       Date:  2013-04-13

7.  Effect of silver nanoparticles on Candida albicans biofilms: an ultrastructural study.

Authors:  Humberto H Lara; Dulce G Romero-Urbina; Christopher Pierce; Jose L Lopez-Ribot; M Josefina Arellano-Jiménez; Miguel Jose-Yacaman
Journal:  J Nanobiotechnology       Date:  2015-12-15       Impact factor: 10.435

8.  Activity of Amphotericin B and Anidulafungin Combined with Rifampicin, Clarithromycin, Ethylenediaminetetraacetic Acid, N-Acetylcysteine, and Farnesol against Candida tropicalis Biofilms.

Authors:  Marcelo Ernesto Fernández-Rivero; José L Del Pozo; Amparo Valentín; Araceli Molina de Diego; Javier Pemán; Emilia Cantón
Journal:  J Fungi (Basel)       Date:  2017-03-22

9.  Verapamil Inhibits Aspergillus Biofilm, but Antagonizes Voriconazole.

Authors:  Hasan Nazik; Varun Choudhary; David A Stevens
Journal:  J Fungi (Basel)       Date:  2017-09-20

10.  Candida albicans Biofilm Heterogeneity and Tolerance of Clinical Isolates: Implications for Secondary Endodontic Infections.

Authors:  Om Alkhir Alshanta; Suror Shaban; Christopher J Nile; William McLean; Gordon Ramage
Journal:  Antibiotics (Basel)       Date:  2019-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.